In this debut episode of OlympusTalks, Host Tom Salemi welcomes Olympus Corporation of the Americas’ Vice President of Endoscopy Marketing Kurt Cannon, and colorectal cancer survivor and advocate Brooks Bell for a candid discussion on the importance of early screening. They explore Olympus’ role in advancing endoscopic technology and how it contributes to early detection and prevention of colon cancer. 

Bell shares her personal experience with early-onset colorectal cancer, highlighting the urgent need to shift cultural perceptions around colonoscopies. She discusses her work through Worldclass Clothing, a nonprofit aimed at removing barriers to screening. Cannon elaborates on Olympus' commitment to improving adenoma detection rates and sheds light on how their latest innovation, the EVIS X1™ endoscopy system, is designed to support this mission.

Colorectal cancer is rising in younger adults—but early screening can make all the difference. Tune in to hear how innovation, advocacy, and awareness are coming together to tackle colorectal cancer.  

For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts. 

*Brooks Bell is a paid endorser of Olympus Corporation, its subsidiaries, and/or its affiliates.

**The content of this podcast was paid for by Olympus.

ADDITIONAL RESOURCES: 

• To learn more about the EVIS X1™ Endoscopy System, visit https://medical.olympusamerica.com/products/evis-x1.

• For resources on colorectal cancer screening and to read patient stories, visit https://www.colonoscopytoday.com/.  

To follow OlympusTalks on your favorite podcast player and YouTube, please visit: https://olympustalks.castos.com/subscribe 

Thank you for listening to the OlympusTalks podcast!

In this episode of the DeviceTalks Weekly Podcast, we’ll get a small taste of what’s to come at DeviceTalks Boston. Host Tom Salemi interviews Paul Grand of MedTech Innovator, Holly Scott of The Mullings Group, and Peter Stebbins of Satio about the state of startups in Boston and the hot topics in MedTech.

Managing Editor Kayleen Brown warms up for her fireside chat with Charisse Sparks, MD, former chief medical officer at Inspire Medical Systems. Dr. Sparks will be the opening keynote interview on Day 2 of DeviceTalks Boston.

Don’t miss it! Register at Boston.DeviceTalks.com. Use the code mentioned inside to save 25%.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode: https://devicetalks.castos.com/subscribe

AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott's senior leaders.

Host Tom Salemi and new co-host Kayleen Brown welcome Vish Charan, divisional vice president of product development for Abbott's Cardiac Rhythm Management, to explore the engineering evolution of the pacemaker—and where it’s headed next.

Charan reflects on the remarkable transformation of pacemakers from large, wired implants to compact, leadless systems that dramatically improve patient outcomes. He details Abbott’s development of the AVEIR™ DR dual chamber leadless pacemaker system, the first of its kind to enable synchronized communication between the atrium and ventricle without leads, using Abbott’s proprietary i2i™ (implant-to-implant) technology.

The conversation dives deep into conduction system pacing, modular upgrades, and how Abbott is shaping the future of cardiac care for millions of patients. The episode closes with a powerful story of a former professional surfer whose life was transformed by Abbott’s innovation—an example of technology enabling patients to reclaim their lives.

Thank you to FPT Americas for sponsoring this episode of AbbottTalks. For more information on how FPT works with medical device companies, visit https://fptsoftware.com/ 

Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe.

In this episode of the DeviceTalks Weekly Podcast, Tom Salemi talks with seasoned MedTech executive Daniel Levangie about the blood-brain barrier-breaking technology being developed by CereVasc.

The company has developed a less invasive way of treating patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults. But the company’s tech gives physicians access to the brain, creating a potentially huge opportunity for future applications.

Just prior to the keynote interview, Tom talks with orthopedic surgeon and OrthoShow podcast host Scott Sigman, MD, about the Future of Orthopedics, a conversation they’ll resume at the start of DeviceTalks Boston.

Go to Boston.DeviceTalks.com to register to attend the April 30-May 1 conference. Use the code mentioned frequently in the podcast to save 25%.

But we’ll start off with MassDevice Editor Chris Newmarker’s Newsmakers - Abbott, Boston Scientific, Edwards Lifesciences, EBR Systems, and Johnson & Johnson MedTech.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

TODAY we will hear from Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, on how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case.

Get Ready. 

In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case.

Nuzzolese explains how Edwards takes a "plan, make, source, deliver" approach, and why MedTech supply chains differ from consumer goods with a stronger emphasis on quality and availability. He details how the company strategically leverages dual sourcing, inventory buffering, and global distribution flexibility to maintain operations, even when borders close or suppliers face challenges.

He also unpacks the need for automation and digital integration, explains how Edwards connects employees to patient outcomes to instill purpose, and reveals why fostering innovation readiness is central to their long-term strategy.

Thank you to Daikin America for sponsoring this episode of Structural Heart Talks. To learn more about Daikin America’s products for your medical application visit https://daikin-america.com.

Wait, there’s more! Want to learn more about Daikin America’s new Co-Extrusion technology? Click here for a high resolution image with more detail.

Thank you for listening to the Structural Heart Talks podcast. 

Subscribe to Structural Heart Talks or the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks on YouTube Podcasts to ensure you never miss an episode.

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi tracks the career of CorVista Health CEO Adrian Lam, an engineer turned financer turned VC turned CEO.

CorVista is bringing AI to bear on cardiac diagnostics, helping hospitals and doctors identify who need the most care.

Before that talk we’ll hear from Scott Frasier of Fraser Healthcare about what ambulatory surgery centers mean for the future of MedTech.

Finally, MassDevice Editor Chris Newmarker and Tom talk about the impact President Trump’s tariff tactics are having on the MedTech industry.

This episode is brought to you by DeviceTalks Boston, April 30 - May 1. Boston.DeviceTalks.com

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, Dr. Nadine Hashash-Haram discusses her journey as a surgeon and the founder of Proxime, a digital health platform that enhances surgical procedures through technology. She shares insights on the evolution of Proxime, its impact on healthcare systems, and the importance of collaboration with medical device companies.

Before that interview, Jonathan Norris, managing director at HSBC Innovation Banking, reviews first quarter MedTech VC investment numbers. There’s good news, bad news and a lot of in-between as privately held medical device companies.

This episode is sponsored by DeviceTalks Minnesota. Find the discount code inside this podcast. Go to Minnesota.DeviceTalks.com to register for the June 11 event.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this week’s episode of the DeviceTalks Weekly Podcast, Andrew Cleeland, CEO of the Fogarty Institute, shares his MedTech story, starting with a serendipitous move into the industry. Cleeland, of course, went on to lead two successful startups from The Foundry - Ardian and Twelve, that both went on to be acquired by Medtronic. Cleeland now leads one of the industry’s most successful incubator programs, the Fogarty Institute.  Cleeland will share insights on leading a MedTech start-up and shares some concerns he has for the industry at large.

The Fogarty Institute is also promoting the Thomas J. Fogarty prize for medical innovation, a $100,000 prize for one person or a small group of people who have broken new ground in the industry. Go to this article at Medical Design & Outsourcing for more information.

https://www.medicaldesignandoutsourcing.com/mike-mussallem-tom-fogarty-prize-medtech-innovation/

Before that conversation, Host Tom Salemi and Holly Scott, managing partner at The Mullings Group, interviewed Cecilia Soriano, global president of Infusion Therapies and Technologies, at Baxter. We’ll preview Soriano’s interview at DeviceTalks Boston where she’ll talk about Baxter’s recovery from Hurricane Helene.

But we’ll start the episode off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers including the FDA, HHS, Alcon, Abbott and Johnson & Johnson MedTech.

Thanks for listening to this episode of the DeviceTalks Weekly podcast.